Cochrane · systematic review · CD011605
Fentanyl for neuropathic pain in adults
Derry, S, Stannard, C, Cole, P, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
Pain, Palliative and Supportive CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
5
No studies
1
Included studies
NR
No studies 1 · 16.7%Ungraded 0 · 0%Very low 5 · 83.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: Adults with chronic neuropathic pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Moderate benefit: at least 30% reduction in pain, or PGIC much or very much improved | no estimate extracted | 1 study · 163 participants | Very low |
Substantial benefit: at least 50% reduction in pain, or PGIC much improved | no estimate extracted | NR | No studies |
Lack of efficacy withdrawal in randomised double‐blind phase | no estimate extracted | 1 study · 163 participants | Very low |
Adverse event withdrawal in randomised double‐blind phase | no estimate extracted | 1 study · 163 participants | Very low |
Serious adverse events | no estimate extracted | 1 study · 258 participants | Very low |
Deaths | no estimate extracted | 1 study · 258 participants | Very low |